| Views | |
|---|---|
| CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation Study | 106 |
| July 2024 | August 2024 | September 2024 | October 2024 | November 2024 | December 2024 | January 2025 | |
|---|---|---|---|---|---|---|---|
| CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation Study | 2 | 1 | 1 | 1 | 1 | 1 | 0 |
| Views | |
|---|---|
| SCOPUS19337213-2016-SID84975221908-a1.pdf | 13 |
| Views | |
|---|---|
| Russia | 78 |
| Views | |
|---|---|
| Kazan | 78 |